OraSolv AB logo

OS BTA - OraSolv AB Share Price

SEK0.15 0.0  0.0%

Last Trade - 27/12/17

Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £9.37m
Position in Universe th / 1782
Unlock OS BTA Revenue
Relative Strength (%)
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2012 2013 2014 2015 2016 2017 2018E 2019E CAGR / Avg
62.1 59.9 66.5 90.8 105.8 108.8 118 122 +11.9%
Balance Sheet
FINANCIAL BRIEF: : For the three months ended 31 March 2018, OraSolv AB revenues decreased 1% to SEK29.6M. Net loss increased 80% to SEK900K. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Other Income decrease from SEK100K (income) to SEK0K.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


OS BTA Revenue Unlock OS BTA Revenue

Net Income

OS BTA Net Income Unlock OS BTA Revenue

Normalised EPS

OS BTA Normalised EPS Unlock OS BTA Revenue

PE Ratio Range

OS BTA PE Ratio Range Unlock OS BTA Revenue

Dividend Yield Range

OS BTA Dividend Yield Range Unlock OS BTA Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
OS BTA EPS Forecasts Unlock OS BTA Revenue
Profile Summary

OraSolv AB is a Sweden-based company active within the dental care sector. Its activities include the acquisition, development and processing of companies and clinics active within the dental care industry. It is also active within the development, manufacture and marketing of products and procedures for less invasive dentistry. Its product portfolio includes Carisolv, a method for tissue-preserving caries removal; Perio+, a periodontitis treatment, and Mano+, a disinfecting, softening and moisturizing hand gel. It is active through its three wholly-owned subsidiaries: Orasolv Clinics AB, operating clinics network; Orasolv Products AB, engaged in the research, development and marketing of product portfolio, and Preventum Partner AB, comprising economic, legal and quality control support services for the dental care sector, as well as educational activities. The Company operates as a subsidiary of ME Dental AB.

Last Annual December 31st, 2017
Last Interim March 31st, 2018
Public Since June 1, 2004
No. of Shareholders: n/a
No. of Employees: 99
Sector Healthcare
Industry Healthcare Providers & Services
Exchange AktieTorget Stock Exchange (Dual Listing)
Shares in Issue 248,279,032
Free Float (0.0%)
Eligible for
OS BTA Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for OS BTA
Upcoming Events for OS BTA
Frequently Asked Questions for OraSolv AB
What is the OraSolv AB share price?

As of 27/12/17, shares in OraSolv AB are trading at SEK0.15, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the OraSolv AB share price performed this year?

Shares in OraSolv AB are currently trading at SEK0.15 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the OraSolv AB price has moved by % over the past year.

What are the analyst and broker recommendations for OraSolv AB?

There are no analysts currently covering OraSolv AB.

When will OraSolv AB next release its financial results?

OraSolv AB is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2019-03-31
What is the OraSolv AB dividend yield?

OraSolv AB does not currently pay a dividend.

Does OraSolv AB pay a dividend?

OraSolv AB does not currently pay a dividend.

When does OraSolv AB next pay dividends?

OraSolv AB does not currently pay a dividend.

How do I buy OraSolv AB shares?

To buy shares in OraSolv AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of OraSolv AB?

Shares in OraSolv AB are currently trading at SEK0.15, giving the company a market capitalisation of £n/a.

Where are OraSolv AB shares listed? Where are OraSolv AB shares listed?

Here are the trading details for OraSolv AB:

Country of listing: Sweden
Exchange: AKT
Ticker Symbol: OS BTA
What kind of share is OraSolv AB?

We were not able to load our ranking data for OraSolv AB

Is there a OraSolv AB share price forecast 2020?

We were not able to load any forecast data for OraSolv AB.

How can I tell whether the OraSolv AB share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like OraSolv AB. Over the past six months, the relative strength of its shares against the market has been %. At the current price of SEK0.15, shares in OraSolv AB are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the OraSolv AB PE Ratio?

We were not able to find PE ratio data for OraSolv AB.

Who are the key directors of OraSolv AB?

We were unable to find the directors for OraSolv AB.

Who are the major shareholders of OraSolv AB?

Here are the top five shareholders of OraSolv AB based on the size of their shareholding:

Similar to OS BTA
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.